California Nanotechnologies (CNO) AI Stock Analysis

• Market Cap: C$16.78M
• Dividend Yield: N/A
• Average Volume (3M): 35.75K
• Price to Earnings (P/E): ―
• Beta (1Y): 3.99
• Revenue Growth: -15.84%
• EPS Growth: -375.96%
• Country: CA
• Employees: N/A
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 0.00
• Shares Outstanding: 50,097,970
• 10 Day Avg. Volume: 35,432
• 30 Day Avg. Volume: 35,752
• PEG Ratio: 0.94
• Price to Book (P/B): 8.69
• Price to Sales (P/S): 3.23
• P/FCF Ratio: 25.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: C$0.50 ▲(47.06% Upside)

The overall stock score is primarily influenced by financial performance, which shows strong revenue growth but is offset by profitability challenges and high leverage. Technical analysis indicates a bearish trend with weak momentum, while valuation concerns arise from a negative P/E ratio and lack of dividend yield.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a healthy expansion trajectory, suggesting strong demand for CNO's nanotechnology solutions across its key sectors.

Cash Flow Generation

Strong cash flow generation provides a solid foundation for future financial stability, enabling CNO to invest in R&D and strategic partnerships.

Improved Equity Position

Improved equity positions suggest enhanced financial stability, reducing risk and potentially lowering the cost of capital for future growth.

Negative Factors

Profitability Challenges

Weak profitability metrics highlight challenges in converting revenue growth into net income, which could impact long-term financial sustainability.

High Leverage

High leverage poses a risk to financial stability, potentially limiting CNO's ability to finance new projects or weather economic downturns.

Volatility in Funding Strategies

Volatility in funding strategies could lead to inconsistent capital availability, affecting CNO's ability to maintain steady growth and operational efficiency.

California Nanotechnologies Business Overview & Revenue Model

Company Description

California Nanotechnologies (CNO) is a leading company focused on the development and commercialization of advanced nanomaterials and nanotechnology solutions. Operating primarily in the sectors of aerospace, defense, and electronics, CNO specializes in creating high-performance materials that enhance the functionality and efficiency of various applications. The company offers a range of products, including nano-coatings, composite materials, and advanced manufacturing processes that leverage nanotechnology to improve product performance and durability.

How the Company Makes Money

California Nanotechnologies generates revenue through multiple streams, including the sale of proprietary nanomaterials and coatings to industries such as aerospace, electronics, and defense. The company also engages in research and development contracts with government and private sector clients, providing tailored solutions that meet specific industry needs. Additionally, CNO benefits from strategic partnerships with major corporations and research institutions, which facilitate access to new markets and collaborative projects. Licensing agreements for its technologies further contribute to its earnings, allowing other businesses to incorporate CNO's innovations into their own products and processes.

California Nanotechnologies Financial Statement Overview

Summary

California Nanotechnologies shows promising revenue growth and improving equity positions, but profitability challenges and high leverage present potential risks. Strong cash flow generation provides a solid foundation for future financial stability.

Income Statement

The company has shown strong revenue growth, with significant increases in total revenue each year, indicating a healthy expansion trajectory. However, profitability metrics such as net profit margin are weak due to a negative net income in the latest period, which impacts the overall score. Gross profit margin is robust, reflecting efficient cost management, but the net loss in the TTM period is a concern.

Balance Sheet

The balance sheet reveals high leverage, with a substantial debt-to-equity ratio due to negative equity in previous years. The equity ratio has improved but remains low, showing risk in financial stability. The recent positive stockholders' equity is a positive sign, indicating improved financial health.

Cash Flow

Cash flow performance is strong, with positive free cash flow growth and a high operating cash flow to net income ratio, which indicates good cash generation relative to income. However, fluctuations in financing cash flow might indicate volatility in funding strategies.

Breakdown	TTM	Dec 2024	Dec 2024	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.19M	3.34M	6.22M	1.82M	1.36M	1.10M
Gross Profit	3.85M	2.33M	4.59M	669.57K	514.32K	523.36K
EBITDA	-340.99K	753.02K	780.97K	337.91K	314.81K	141.12K
Net Income	-1.30M	381.68K	-158.33K	79.76K	200.60K	-74.36K
Balance Sheet
Total Assets	4.76M	2.36M	5.50M	1.41M	1.22M	864.54K
Cash, Cash Equivalents and Short-Term Investments	462.81K	841.35K	533.85K	294.13K	65.11K	56.31K
Total Debt	1.55M	1.21M	1.62M	1.94M	2.15M	2.31M
Total Liabilities	2.59M	2.21M	3.19M	2.70M	2.58M	2.47M
Stockholders Equity	2.17M	145.97K	2.32M	-1.29M	-1.36M	-1.61M
Cash Flow
Free Cash Flow	1.16M	89.98K	797.00K	604.26K	45.29K	180.62K
Operating Cash Flow	3.28M	104.28K	2.92M	717.01K	54.97K	180.62K
Investing Cash Flow	-2.10M	-14.30K	-2.11M	-112.75K	―	0.00
Financing Cash Flow	-1.20M	535.33K	-1.12M	-387.83K	―	-149.61K

California Nanotechnologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.34
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.36, below the 50-day MA of 0.38, and below the 200-day MA of 0.52, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 42.62 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CNO.

California Nanotechnologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
HG	54 Neutral	C$1.19B	-126.76	-87.47%	―	331.08%	15.77%
GMG	53 Neutral	C$136.50M	-16.67	-92.59%	―	6.29%	-3.71%
CNO	49 Neutral	C$16.78M	―	-61.05%	―	-15.84%	-375.96%
IZ	45 Neutral	C$424.07K	100.00	―	―	109.13%	―
NANO	45 Neutral	C$183.97M	-16.79	-64.59%	―	―	56.03%

California Nanotechnologies Corporate Events

California Nanotechnologies Secures Orders for Nuclear Reactor Components

California Nanotechnologies Corp. has secured two purchase orders worth approximately $196,250 from a U.S.-based company focused on advanced small modular nuclear reactors. These orders involve the production of boron-carbide reactor control rods for the client’s first demonstration reactor, highlighting Cal Nano’s role in the domestic nuclear supply chain. The company’s expertise in advanced materials and rapid production capabilities were key in securing this partnership. Additionally, Cal Nano will host its inaugural SPS/FAST Experts Workshop in March 2026, showcasing advanced sintering technologies and offering networking opportunities.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.

California Nanotechnologies Secures Key Orders for Nuclear Reactor Components

California Nanotechnologies Corp. has secured two purchase orders worth approximately $196,250 from a U.S.-based company for the production of boron-carbide reactor control rods for small modular nuclear reactors. This development highlights Cal Nano’s capability to meet accelerated timelines and specifications, reinforcing its position as a key player in the nuclear supply chain. The orders will be fulfilled at their Santa Ana facility using advanced sintering technologies, and the company is also set to host an SPS/FAST Experts Workshop in 2026, showcasing their expertise and facilities.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.

California Nanotechnologies Reports Q2 2026 Results Amid Strategic Shift

California Nanotechnologies reported a 49% decrease in quarterly revenue to $780K, attributed to a decline in business from its green steel customer. Despite this, the company achieved a 100% year-over-year increase in manufacturing revenues from other customers, highlighting its efforts to diversify its client base. The company is transitioning towards long-term commercial contracts and announced a Letter of Intent for a $1 million SPS production contract for military brakes. Cal Nano is also exploring advanced armor applications and continues to engage in discussions with potential partners to expand its market presence.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.

California Nanotechnologies to Present at Planet MicroCap Showcase in Toronto

California Nanotechnologies Corp. announced its participation in the Planet MicroCap Showcase in Toronto on October 22, 2025. The event, in partnership with MicroCapClub, provides a platform for the company to present its advancements and engage with investors, potentially enhancing its market visibility and stakeholder engagement.

The most recent analyst rating on (TSE:CNO) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on California Nanotechnologies stock, see the TSE:CNO Stock Forecast page.